← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mimetas Us, Inc.
Gaithersburg, MD
$6,255,385
Total funding
7
Grants
Funding over time
peak $2M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,255,385 · 7
By mechanism
N44$3,500,000 · 2
R44$1,993,146 · 1
N43$522,960 · 2
R43$236,779 · 1
N01$2,500 · 1
Investigators at Mimetas Us, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Topic #355 - SBIR Phase II - A 3D Perfusable Platform for HTS Across Diverse Racial/Ethnic Cancer Spe$2,000,000
N44 · FY2019 · CA
IGF::OT::IGF DEVELOPMENT AND EVALUATION OF THE HEPAPLATE IPS: A HIGH THROUGHPUT ORGAN-ON-ACHIP IPS HEPATOTOXICTY SCREENING PLATFORM$1,500,000
N44 · FY2018 · DA
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies$1,000,000
R44 · FY2022 · DK
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies$993,146
R44 · FY2023 · DK
IGF::OT::IGF SBIR Topic 355: A 3D Perfusable Platform for HTS Across Diverse Racial/Ethnic Cancer Specimens To generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer culture$297,962
N43 · FY2017 · CA
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies$236,779
R43 · FY2020 · DK
IGF::OT::IGF DEVELOPMENT AND EVALUATION OF THE HEPAPLATE IPS: A HIGH THROUGHPUT ORGAN ON A CHIP IPS HEPATOTOXICTY SCREENING PLATFORM$224,998
N43 · FY2016 · DA
Pre-Clinical Models of Infectious Diseases$2,500
N01 · FY2024 · AI